Vitamin D (Ergocalciferol)


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 47.8%
Plasma Cell Myeloma 13.0%
Hypertension 4.3%
Multiple Sclerosis 4.3%
Myelodysplastic Syndrome 4.3%
Back Disorder 2.2%
Bladder Obstruction 2.2%
Fibromyalgia 2.2%
Hypersensitivity 2.2%
Irritable Bowel Syndrome 2.2%
Vitamin D Deficiency 2.2%
Back Pain 2.2%
Depression 2.2%
Gastrooesophageal Reflux Disease 2.2%
High Cholesterol 2.2%
Relapsing-remitting Multiple Sclerosis 2.2%
Vitamin D Deficiency 2.2%
Pain In Extremity 11.8%
Dehydration 5.9%
Drug Interaction 5.9%
Electrocardiogram Pr Prolongation 5.9%
Myocardial Infarction 5.9%
Nausea 5.9%
Plasma Cell Myeloma 5.9%
Plasma Cell Myeloma Recurrent 5.9%
Pruritus Generalised 5.9%
Pulmonary Embolism 5.9%
Rhabdomyolysis 5.9%
Tinea Pedis 5.9%
Urticaria 5.9%
Vision Blurred 5.9%
Vomiting 5.9%
Weight Increased 5.9%
Concomitant
Plasma Cell Myeloma 28.7%
Multiple Sclerosis 27.6%
Product Used For Unknown Indication 8.5%
Gait Disturbance 5.5%
Relapsing-remitting Multiple Sclerosis 4.0%
Myelodysplastic Syndrome 3.6%
Immunodeficiency Common Variable 3.1%
Osteoporosis 2.7%
Hypertension 2.2%
Tuberous Sclerosis 2.2%
Chronic Myeloid Leukaemia 2.0%
Systemic Lupus Erythematosus 1.5%
Acromegaly 1.3%
Breast Cancer 1.3%
Depression 1.1%
Drug Use For Unknown Indication 1.1%
Prophylaxis 1.1%
Blood Cholesterol Increased 0.9%
Supplementation Therapy 0.9%
5Q Minus Syndrome 0.7%
White Blood Cell Count Decreased 10.9%
Vomiting 8.8%
Pyrexia 7.1%
Weight Decreased 6.7%
Tremor 5.9%
Fatigue 5.4%
Rash 5.4%
Visual Impairment 5.4%
Vision Blurred 5.0%
Nausea 4.6%
Upper Respiratory Tract Infection 4.6%
Urinary Tract Infection 4.6%
Pneumonia 4.2%
Paraesthesia 3.3%
Renal Failure 3.3%
Full Blood Count Decreased 2.9%
Pain In Extremity 2.9%
Platelet Count Decreased 2.9%
Pruritus 2.9%
Renal Impairment 2.9%

Drug Data